A Feasibility Study on Using Tablet Personal Computers for Self-reported Symptom Assessment in Newly Diagnosed Lung Cancer Patients
Overview
Affiliations
Aim: The study aimed to assess the feasibility and acceptability of an innovative tablet-assisted self-reported symptom assessment among newly diagnosed lung cancer patients.
Background: Routine symptom assessment for lung cancer patients in a fast-paced clinical environment is demanding. Mobile health technology offers a potential platform for symptom assessment and paves the way for tailored self-care intervention.
Design: A feasibility study using a mixed method design.
Method: A convenience sample of 10 newly diagnosed lung cancer patients used tablet personal computers to self-report common symptoms: dyspnoea, fatigue, pain, and anxiety. A nurse reviewed the assessment results and provided tailored educational interventions. Acceptability was evaluated by the Electronic Self-Report Assessment-Cancer. Semi-structured interviews were conducted to explore the patients' perceptions of this symptom assessment method. Data were collected from January to March 2016.
Results: An Electronic Self-Report Assessment-Cancer mean score of 23.5 (SD 2.7) showed moderate acceptance of the assessment method. Participants found this approach user-friendly and helpful in identifying their symptoms and they gained awareness and better understanding of them.
Conclusion: Tablet-assisted symptom assessment is a feasible method that can be further tested in busy clinical settings to assess symptom burden and identify individual needs for tailoring symptom management plans.
Application of Patient-Generated Health Data Among Older Adults With Cancer: Scoping Review.
Kim Y, Kim G, Cho H, Kim Y, Choi M J Med Internet Res. 2025; 27:e57379.
PMID: 39903506 PMC: 11836591. DOI: 10.2196/57379.
Zhu S, Dong Y, Li Y, Wang H, Jiang X, Guo M J Med Internet Res. 2024; 26:e59061.
PMID: 39466301 PMC: 11555449. DOI: 10.2196/59061.
Macharia J, Raposa B, Sipos D, Melczer C, Toth Z, Kaposztas Z Healthcare (Basel). 2023; 11(22).
PMID: 37998446 PMC: 10671794. DOI: 10.3390/healthcare11222954.
Mizuno M, Chiba I, Mukohara T, Kondo M, Maruo K, Ohigashi T Contemp Clin Trials Commun. 2022; 30:101035.
PMID: 36387994 PMC: 9661427. DOI: 10.1016/j.conctc.2022.101035.
Kanakubo A, Mizuno M, Asano Y, Inoue Y Asia Pac J Oncol Nurs. 2022; 9(2):105-112.
PMID: 35529417 PMC: 9072175. DOI: 10.1016/j.apjon.2021.12.011.